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Abstract. Organic synthesis occupies the central stage of drug discovery.1 However, the 
implementations of organic synthetic methodologies/processes are being critically assessed in the context 
of environmental pollution. This has induced a paradigm change in the practice and development of 
chemical research. In pharmaceutical research, adoption of sustainable chemical processes is a mandatory 
requirement to minimise the adverse effect on the environment2 urging for integrating/incorporating the 
modern synthetic methodologies in discovery medicinal research and enrichment of the medicinal 
chemists’ tool box3 in compliance with the green chemistry principles.4 However, it seems apparent that, 
there is inadequate representation of the modern synthetic methodologies in medicinal chemistry 
practices,5 though the success of drug discovery is critically dependent on the expertise on synthetic 
organic chemistry.6 The lack of incorporation of the modern synthetic methodologies in discovery 
medicinal chemistry limits the exploration within a narrow chemical space resulting in the recurrence of 
certain structural scaffold that might squeeze the IP (Intellectual Property) space. These highlight the 
necessity and advantages of integration of the modern synthetic methodologies for sustainable medicinal 
chemistry research. 
The present talk would involve the design of novel anti-inflammatory scaffolds to generate leads 
for COPD/asthma and rheumatoid arthritis targeting the PDE IV and COX-28 enzymes, respectively. The 
synthesis of the target compounds and optimization of the lead structure will be demonstrated through CX 
(X= Br/O) bond activation by hetero-bimetallic nano clusters9 throughco-operative catalysis and late stage 
functionalization of C-H bond.10 
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